Skip to main content
. 2018 Nov 10;64(3):815–822. doi: 10.1007/s10620-018-5365-0

Table 1.

Patients’ demographic data and severity of gastric atrophy and reflux esophagitis

Esomeprazole group (n = 25) Vonoprazan group (n = 22) P value
Sex (male/female) 10/15 6/16 N.S.
Age (mean ± SD, years) 54.7 ± 13.2 58.0 ± 13.8 N.S.
Body mass index (mean ± SD) 23.1 ± 2.7 25.3 ± 4.0 0.04
Smoking (number, yes/no) 10/15 5/17 N.S.
Alcohol drinking (number, yes/no) 14/11 11/11 N.S.
Gastric atrophy (number, closed type/open type) 19/6 15/7 N.S.
LA classification grade (N or M/A/B/C/D) 13/6/3/2/1 9/7/3/3/0 N.S.
% of LA grade C or D 12.0% 10.5% N.S.